Paul Hastings Advised Wynnchurch Capital in the Acquisition of Reagent Chemical & Research
Paul Hastings LLP advised Wynnchurch Capital, L.P., a leading middle-market private equity investment firm, in the acquisition of Reagent Chemical & Research, LLC.
Founded in 1959, Reagent is the leading specialty distributor of hydrochloric acid in North America.
More details on the transaction can be found here.
Private Equity partner Chris Sheaffer led the Paul Hastings team, which also included partners Jim Smulkowski and Holly Snow; and associates Sam Domjen and Megan Craig.
With widely recognized elite teams across 17 core practices, Paul Hastings is a premier law firm with a culture of excellence focused on providing intellectual capital and superior execution globally to the world's leading investment banks, asset managers and corporations.